Basic Study
Copyright ©The Author(s) 2022.
World J Transl Med. Aug 6, 2022; 10(2): 14-28
Published online Aug 6, 2022. doi: 10.5528/wjtm.v10.i2.14
Figure 2
Figure 2 Intergroup differences in cell-free mitochondrial DNA concentrations and their diagnostic value in patients at disease onset and treatment. A: Significantly decreased cell-free mitochondrial DNA (cf-mtDNA) concentration was observed after 72 h of treatment compared to patients at disease onset aP < 0.01; B-D: Receiver operating characteristic plots showing the diagnostic significance of cf-mtDNA concentrations for discriminating patients at disease onset with 24 h of treatment, and 72 h of treatment. bP < 0.001; cP < 0.0001. AUC: Area under curve; cf-mtDNA: Cell-free mitochondrial DNA; ROC: Receiver operating characteristic.